Literature DB >> 26275893

Complement in ANCA-associated glomerulonephritis.

Marc Hilhorst1, Pieter van Paassen1,2, Henk van Rie1,3, Nele Bijnens1,3, Petra Heerings-Rewinkel1, Peter van Breda Vriesman1, Jan Willem Cohen Tervaert1.   

Abstract

BACKGROUND: Anti-neutrophil cytoplasmic antibodies (ANCA) are found in pauci-immune necrotizing crescentic glomerulonephritis. In the past, the role of complement in ANCA-associated vasculitis (AAV) was assumed to be minimal. More recently, however, it was found that blocking the complement cascade in a mouse model of AAV reduces glomerular damage. Immune complex deposits have been found in biopsies from AAV patients. In this study, we questioned whether immune complex formation or deposition may result in complement activation in ANCA-associated glomerulonephritis.
METHODS: ANCA-positive patients from the Limburg Renal Registry were included between 1979 and 2011. Renal histology was documented together with immunoglobulin and complement immunofluorescence. In addition, C3d, properdin, C4d and mannose-binding lectin (MBL) were stained. Electron microscopy was performed. Circulating immune complexes were determined in a subset of patients, as well as C3 allotypes.
RESULTS: C3c was found in 78 of 187 renal biopsies (41.7%) divided over 32.3% of proteinase-3 (PR3)-AAV patients and 52.3% of myeloperoxidase (MPO)-AAV patients (P = 0.006), whereas C3d was found positive in 51.1% of PR3-AAV patients and 70.4% of MPO-AAV patients (P = 0.105). C4d was found positive in 70.8%, properdin in 38.7% and MBL in 30.4% of patients. Whereas C4d and MBL positivity was similar between the AGN groups, properdin was more common in biopsies classified as crescentic compared with biopsies classified as focal or mixed. Renal biopsies positive for C3d and/or properdin showed more cellular crescents and less normal glomeruli compared with biopsies negative for C3d and/or properdin (P < 0.05). In 3 out of 43 renal biopsies analysed by electron microscopy, small electron dense deposits were found. In 14 of 46 patients analysed, circulating immune complexes were detectable. No association between histological findings and C3 allotypes was found.
CONCLUSIONS: In the majority of AAV patients, no immune complex deposits were found in their renal biopsies. C3d, C4d and C5b-9 staining, however, was found to be positive in a majority of analysed renal biopsies. Importantly, C3d and properdin staining was associated with cellular crescents. We hypothesize that local immune complexes are quickly degraded in AAV and therefore not visible by electron microscopy. Our findings are compatible with the hypothesis that complement activation in AAV occurs predominantly via alternative pathway activation.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  ANCA; complement; glomerulonephritis; renal biopsy

Mesh:

Substances:

Year:  2017        PMID: 26275893     DOI: 10.1093/ndt/gfv288

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  31 in total

Review 1.  Complement in ANCA-associated vasculitis: mechanisms and implications for management.

Authors:  Min Chen; David R W Jayne; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-03-20       Impact factor: 28.314

Review 2.  The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.

Authors:  G Trivioli; A Vaglio
Journal:  Clin Exp Immunol       Date:  2020-10-05       Impact factor: 4.330

Review 3.  Update on ANCA-associated vasculitis: from biomarkers to therapy.

Authors:  Martina Tedesco; Maurizio Gallieni; Francesca Pellegata; Mario Cozzolino; Federico Alberici
Journal:  J Nephrol       Date:  2019-07-12       Impact factor: 3.902

Review 4.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

5.  A case of smoldering antineutrophil cytoplasmic antibody-associated vasculitis development during the course of primary Sjögren's syndrome.

Authors:  Yoichi Iwafuchi; Tetsuo Morioka; Yuko Oyama; Ichiei Narita
Journal:  CEN Case Rep       Date:  2021-11-17

6.  The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis.

Authors:  S Moiseev; J M Lee; A Zykova; N Bulanov; P Novikov; E Gitel; M Bulanova; E Safonova; J I Shin; A Kronbichler; D R W Jayne
Journal:  Clin Exp Immunol       Date:  2020-09-15       Impact factor: 4.330

7.  Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.

Authors:  Matija Crnogorac; Ivica Horvatic; Patricia Kacinari; Danica Galesic Ljubanovic; Kresimir Galesic
Journal:  J Nephrol       Date:  2017-10-13       Impact factor: 3.902

8.  Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis.

Authors:  Jean-François Augusto; Virginie Langs; Julien Demiselle; Christian Lavigne; Benoit Brilland; Agnès Duveau; Caroline Poli; Alain Chevailler; Anne Croue; Frederic Tollis; Johnny Sayegh; Jean-François Subra
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 9.  Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Authors:  Peter Lamprecht; Anja Kerstein; Sebastian Klapa; Susanne Schinke; Christian M Karsten; Xinhua Yu; Marc Ehlers; Jörg T Epplen; Konstanze Holl-Ulrich; Thorsten Wiech; Kathrin Kalies; Tanja Lange; Martin Laudien; Tamas Laskay; Timo Gemoll; Udo Schumacher; Sebastian Ullrich; Hauke Busch; Saleh Ibrahim; Nicole Fischer; Katrin Hasselbacher; Ralph Pries; Frank Petersen; Gesche Weppner; Rudolf Manz; Jens Y Humrich; Relana Nieberding; Gabriela Riemekasten; Antje Müller
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

10.  A rare case of Alport syndrome, atypical hemolytic uremic syndrome and Pauci-immune crescentic glomerulonephritis.

Authors:  Jianling Tao; Jonathan Lieberman; Richard A Lafayette; Neeraja Kambham
Journal:  BMC Nephrol       Date:  2018-12-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.